Dr. Robert Alan Probe, MD

Dr. Probe practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Probe's NPI, 1871554295, was assigned on March 28, 2006. Dr. Probe graduated from Texas A&M College of Medicine - Bryan in 1984. Dr. Probe's Texas license number on file is G8951.

Dr. Probe's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Probe's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Probe is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Probe practices, 2 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Probe's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Probe is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Probe has a license on file in Texas.

Dmand AI lists amputation, arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, enthesopathy in foot or ankle, fluid in a joint, hip replacement and joint or bone infection among the conditions Dr. Probe treats.

CMS data shows 155 Medicare services from Dr. Probe across 2 procedure codes in 2024, all of them office visits, for 114 Medicare patients. Medicare paid $7,225 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Probe in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Probe's median patient age at 68, with 58% women.

In 2024, Dr. Probe wrote 99 Medicare Part D claims for 54 patients. 98% of them were for generic drugs. CMS names the drug for 58 of them, across 2 drugs with 11 or more claims each, at $345 in total drug cost. In 2023, CMS named 106 claims across 3 drugs.

Dr. Probe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 46 papers to Dr. Probe, published from 2010 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Fracture Fixation, Internal, Femoral Fractures and Fracture Fixation, Intramedullary. Dr. Probe has published most often in J Orthop Trauma. Dr. Probe's most frequent co-authors are Ronald Wayne Lindsey, MD, Christopher D. Chaput, MD and Theodore Miclau, MD.

Dmand AI links Dr. Probe to 1 clinical trial. Conditions studied include Femoral Neck Fractures and Hip Fractures.

CMS Open Payments shows 57 general payments to Dr. Probe from 7 drug and device companies from 2016 to 2025. Education make up the largest share, 49% of the total. Stryker Corporation paid the most, $3,261.

Dmand AI lists 8 awards for Dr. Probe, most recently Scott & White GME Distinguished Alumni in 2008.

Dr. Probe graduated from Texas A&M College of Medicine - Bryan in 1984. Dr. Probe is a member of OTA.

Dr. Probe is in network with 16 carriers, including United Healthcare, Aetna and Elevance. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.